The STEP-1 trial demonstrated that in patients who were overweight or obese, semaglutide 2.4 mg vs
In fact, liraglutide, the generic form of Saxenda now being produced by Teva, shares over 97% sequence homology with human-derived GLP-1
Health Conditions: GLP-1 agonists: Medication may be better for those with type 2 diabetes or prediabetes, as they improve glycemic control and support weight loss
The study, along with prior research and cardiovascular trials, suggests that GLP1 receptor agonists may offer a broad survival benefit through combined cardiometabolic and cellular effects
When applied topically, it reduces melanin production, heals sun damage, treats hyperpigmentation, fades stubborn scars & protects the skin's collagen
Here is an example of one study done in adolescents